Tokyo, Japan and Cambridge, UK, 28 February 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces that it has entered a license, supply and commercialization agreement with Holling Bio-Pharma Corp. (“Holling”) for daridorexant in Taiwan.
Nxera Pharma Enters Agreement with Holling to Commercialize Daridorexant in Taiwan
Seeking Alpha / 4 minutes ago 1 Views
Comments